News & InsightsNewsletterLegislation Hub

Foresight

Foresight
AboutContactLog in
Book a Demo
Foresight logo
All News & Insights

Concerns Loom Over Incoming Trump Administration’s Approach to Lautenberg Chemical Safety Act

TSCA
26
January 2025
•
400
Dr Steven Brennan
A Congressional hearing reviews the Lautenberg Chemical Safety Act, highlighting EPA delays, industry concerns, and public health protection needs.
Congressional hearing reviews on Youtube
Quick prompts

AI Generated

Get to the point quicker with prompts - a smarter way to get the information you need from our articles.

Summarise this article

The U.S. Congress held a hearing on the Lautenberg Chemical Safety Act, assessing its impact on public health and industry. Key challenges include EPA delays, insufficient funding, and regulatory inefficiencies. Stakeholders stressed the need for reforms to balance chemical safety with innovation and economic growth.

What was the purpose of the Congressional hearing on the Lautenberg Chemical Safety Act?

The hearing aimed to assess the effectiveness and challenges of the Lautenberg Act nearly a decade after its passage. It focused on the EPA's implementation of the Act, the delays in chemical reviews, the impact on public health, and the balance between industrial innovation and regulatory oversight.

What were the key concerns raised about the EPA during the hearing?

During the hearing, key concerns were raised about the EPA's implementation of the Lautenberg Chemical Safety Act, particularly its significant delays in chemical reviews. A GAO report revealed that 90% of pre-manufactured chemical reviews missed statutory deadlines, with some evaluations taking years to complete, which has slowed the introduction of safer chemicals. Witnesses also highlighted the EPA’s resource constraints, including staffing shortages and insufficient funding, which have hampered its ability to fulfill its responsibilities efficiently. Concerns about inconsistent decision-making were also discussed, as review outcomes often varied based on individual reviewers, leading to unpredictability in the regulatory process. Public health advocates stressed the importance of strengthening protections for vulnerable communities disproportionately exposed to hazardous chemicals, urging the EPA to consider real-world exposures in its evaluations. Meanwhile, industry leaders argued that the EPA’s cautious regulatory approach has stifled innovation and pushed manufacturing overseas, underscoring the need for reforms that balance robust safety protections with fostering industrial growth.

AI Assistant

This feature and much more is available on our platform. If you would like early access, please leave your email and we'll get in touch.

We'll be in touch when the Assistant is ready.
Oops! Something went wrong while submitting the form.
Mountains

As the U.S. prepares for the incoming Trump administration, a recent Congressional hearing on the Lautenberg Chemical Safety Act raised alarms about potential deregulation and the prioritisation of corporate interests over public health. Lawmakers, public health advocates, and industry leaders assessed the Environmental Protection Agency’s (EPA) implementation of the Act, highlighting the need to protect its integrity amid fears of a rollback of critical safety standards.

Trump Administration Sparks Concerns Over Chemical Safety

A History of Progress at Stake

Passed in 2016, the Lautenberg Chemical Safety Act modernised the outdated Toxic Substances Control Act (TSCA), empowering the EPA to regulate hazardous chemicals like asbestos, methylene chloride, and trichloroethylene. These substances, linked to cancer and other severe health risks, had long been underregulated.

Dr. Maria Doa, Senior Director of Chemical Policy at the Environmental Defense Fund, lauded the Act for its transformative impact:

“The Lautenberg Act transformed what was once a largely ineffective law into one that set a clear directive to protect human health and the environment.”

However, lawmakers expressed concerns that the incoming administration could undermine this progress by focusing on deregulation and weakening EPA enforcement.

Pallone’s Warning on Deregulation

Ranking Member Frank Pallone voiced his apprehension, stating:

“The Trump administration has already shown itself to be more interested in special corporate interests than the health of American families, workers, and communities.”

This sentiment was echoed by public health advocates who stressed the importance of preserving the Lautenberg Act’s provisions to prevent hazardous chemicals from entering American homes and workplaces.

Industry and Public Health at a Crossroads

EPA Delays and Resource Challenges

The hearing also highlighted ongoing delays in EPA chemical reviews. A Government Accountability Office (GAO) report revealed that 90% of pre-manufactured chemical reviews missed statutory deadlines between 2017 and 2022, hindering the rollout of potentially safer chemicals.

While industry leaders called for process reforms, they warned against losing the foundational protections established by the Act. Christopher John, President of the American Chemistry Council, stated:

“Delays and uncertainty make it more likely that manufacturers will bring products to market overseas, jeopardizing U.S. competitiveness.”

Protecting Vulnerable Communities

Advocates like Dr. Doa emphasised the importance of the EPA maintaining rigorous oversight, particularly for communities disproportionately affected by toxic exposure. She urged vigilance, warning against introducing new carcinogens to the market under a more lenient regulatory framework.

What Lies Ahead for Chemical Safety?

Balancing Innovation and Safety

The Trump administration’s approach to environmental and chemical safety regulations remains uncertain, but lawmakers stressed the need to protect the Act’s bipartisan foundation. The Lautenberg Act represents a critical balance between fostering innovation and safeguarding public health.

Chairman Morgan Griffith remarked:

“A healthy nation, a secure nation, an economically vibrant nation relies on chemistry.”

However, achieving this vision requires the EPA to overcome resource constraints and ensure timely and consistent chemical reviews.

Moving Forward: Protecting the Lautenberg Act

As the Trump administration begins, public health advocates, lawmakers, and industry leaders agree on the need to uphold the Lautenberg Act’s integrity. While streamlining regulatory processes is essential, any rollback of safety standards could risk undoing years of progress in protecting vulnerable communities and fostering trust in chemical safety.

Read the source story

Read this article now for free!

You have read 3 articles.
Create a free account
or
Log in
to finish reading this article now.

Subscribe to our weekly digest

Sign up to receive our newsletter every Tuesday and get access to all of our content.

By creating an account, you agree to the Terms of Service and Privacy Policy.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
This is some text inside of a div block.

Trusted by professionals at

Dupont
ECHA - European Chemicals Agency
Energizer
Chemours
This is some text inside of a div block.

Get Foresight Today

Stay compliant, reduce risk, and protect your business with our AI-powered chemical policy monitoring—tailored just for you.

Global monitoring of 1,200+ sources
Expert-reviewed, trusted regulatory alerts
Instant risk identification for 350k+ substances

Ready to supercharge your policy monitoring workflow?

We’ll be in touch soon with more details and support to help you get started.
Oops! Something went wrong while submitting the form.
Share with a friend
Copy link

Related Articles

CoatingsEPA Proposes SNURs for 37 New Chemical Substances

April 17, 2025

Industrial chemical plantEPA Releases Draft Scope for Vinyl Chloride Risk Evaluation Under TSCA

January 21, 2025

Construction productsEPA Identifies Significant Health Risks from Diisononyl Phthalate (DINP) Under TSCA Evaluation

January 16, 2025

Foresight regulatory experts
Streamline your chemical compliance
Easy-to-use product compliance management for small and mid-sized manufacturers — mitigate risk and protect market access.
Get started
Subscribe to Foresight's newsletter
Stay ahead with the latest news & insights
Join 1,000s of compliance professionals getting the latest insights right to their inbox for free, every Tuesday.
100% free. No spam. Unsubscribe any time.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Stay ahead with the latest news & insights
Subscribe to our free weekly newsletter covering news, events, and expert insights.

Related articles

Coatings

EPA Proposes SNURs for 37 New Chemical Substances

EPA proposes SNURs for 37 chemicals under TSCA, impacting US manufacturing. Review the changes and ensure compliance before 6 May 2025.

17

Apr 2025

TSCA
Congressional hearing reviews on Youtube

Concerns Loom Over Incoming Trump Administration’s Approach to Lautenberg Chemical Safety Act

A Congressional hearing reviews the Lautenberg Chemical Safety Act, highlighting EPA delays, industry concerns, and public health protection needs.

26

Jan 2025

TSCA
Industrial chemical plant

EPA Releases Draft Scope for Vinyl Chloride Risk Evaluation Under TSCA

EPA releases draft scope for vinyl chloride risk evaluation under TSCA. Public comments invited until 3 March 2025.

21

Jan 2025

TSCA
Foresight
Providing critical insights, analysis, and guidance to help businesses anticipate changes, make informed decisions, and stay ahead.
News & Insights
Newsletter
Legislation Hub
Coverage
Contact
About
© 2025 Foresight. All rights reserved.
SitemapTerms of servicePrivacy policyCookie policy